Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. (Q38940398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

title

Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

11

Katherine K Matthay

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

7

John M Maris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Kelly E Huibregtse

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

Kieuhoa T Vo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

Steven G DuBois

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

Stephanie Fetzko

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

John Neuhaus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

Vandana Batra

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

Araz Marachelian

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

Greg A Yanik

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

publication date

27 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

European Journal of Cancer

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

144-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy

22 March 2020

cites work

1 reference

12 December 2020

Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma

1 reference

12 December 2020

Radiation dose and breast cancer risk in the childhood cancer survivor study

1 reference

12 December 2020

Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine

1 reference

12 December 2020

Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma

1 reference

12 December 2020

Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology

1 reference

12 December 2020

Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With 131 I-Metaiodobenzylguanidine (MIBG).

1 reference

12 December 2020

Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems

1 reference

12 December 2020

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

1 reference

12 December 2020

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

1 reference

12 December 2020

Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma

1 reference

12 December 2020

Children's Oncology Group's 2013 blueprint for research: neuroblastoma

1 reference

12 December 2020

Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma

1 reference

12 December 2020

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.

1 reference

12 December 2020

Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment.

1 reference

12 December 2020

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma

1 reference

12 December 2020

Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation

1 reference

12 December 2020

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

1 reference

12 December 2020

Long-term complications in survivors of advanced stage neuroblastoma

1 reference

12 December 2020

Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.

1 reference

12 December 2020

131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma.

1 reference

12 December 2020

Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study

1 reference

12 December 2020

Report of the Cancer Therapy Evaluation Program monitoring plan for secondary acute myeloid leukemia following treatment with epipodophyllotoxins

1 reference

12 December 2020

Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study

1 reference

12 December 2020

Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma

1 reference

12 December 2020

A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma

1 reference

12 December 2020

Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.

1 reference

12 December 2020

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

1 reference

12 December 2020

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

1 reference

12 December 2020

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

12 December 2020

Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experience

1 reference

12 December 2020

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

1 reference

12 December 2020

10.1016/J.EJCA.2016.07.017

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27573428 AND SRC:MED&resulttype=core&format=json

22 March 2020

1 reference